Chengdu Kangnuoxing Biopharma,Inc.
Works in Dermatology · ENT · Genetic & rare · Immunology · Respiratory
Chengdu Kangnuoxing Biopharma,Inc. is a clinical trial sponsor. It has 6 active clinical trials with 2,351 planned participants, across 5 therapeutic areas.
Trial track record · since 2021
Pipeline · 6 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Chengdu Kangnuoxing Biopharma,Inc
Chengdu Kangnuoxing Biopharma,Inc is lead sponsor of 6 active clinical trials on ClinicalTrials.gov, with 2,351 planned participants, in Dermatology, ENT, Genetic & rare, Immunology and other areas. Since 2021 it has completed 0 trials and stopped 0 early.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Chengdu Kangnuoxing Biopharma,Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-03.
Approve Suite is not affiliated with Chengdu Kangnuoxing Biopharma,Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.